{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Foster City",
      "address_1": "333 Lakeside Drive",
      "reason_for_recall": "Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).",
      "address_2": "",
      "product_quantity": "3,181 vials",
      "code_info": "Lot #: B120217A, Exp 05/15 - US Distribution",
      "center_classification_date": "20130516",
      "distribution_pattern": "Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.",
      "state": "CA",
      "product_description": "Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA  94404, UPC 3 61958 01011 5; NDC 61958-0101-1.",
      "report_date": "20130522",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Gilead Sciences, Inc.",
      "recall_number": "D-324-2013",
      "initial_firm_notification": "E-Mail",
      "product_type": "Drugs",
      "event_id": "64267",
      "termination_date": "20140106",
      "more_code_info": "",
      "recall_initiation_date": "20130131",
      "postal_code": "94404-1147",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}